IPO registrations (S-1, F-1) · Registrants
Allarity Therapeutics, Inc.
- SEC CIK
- 1860657 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2021-09-13, last 2024-04-17; 4 initial registrations, 13 amendments
- Outcome
- Final prospectus filed 2023-04-20; declared effective 2021-11-05; withdrawal requested 2024-05-08
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 24 SCHOOL ST., 2ND FLOOR, Boston, MA 02108
- Ticker
- ALLR (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Allarity Therapeutics, Inc. on the corporate pages
Offering terms
- Shares offered
- 2,869,330
- Listing
- Nasdaq under the symbol ALLR
- Lead underwriters
- A.G.P./Alliance Global Partners
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: Allarity Therapeutics, Inc. EXACT (CIK (EXACT))
- SEC filer: Allarity Therapeutics, Inc. EXACT (CIK (EXACT))
Filings 31
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-09-13 | S-1 | S-1 (registration) | Allarity Therapeutics, Inc. | 0001213900-21-047633 ↗ |
| 2021-10-12 | S-1/A | S-1/A (amendment) | Allarity Therapeutics, Inc. | 0001213900-21-052418 ↗ |
| 2021-11-05 | EFFECT | EFFECT (declared effective) | Allarity Therapeutics, Inc. | 9999999995-21-004222 ↗ |
| 2021-11-05 | EFFECT | EFFECT (declared effective) | Allarity Therapeutics, Inc. | 9999999995-21-004224 ↗ |
| 2021-12-06 | S-1/A | S-1/A (amendment) | Allarity Therapeutics, Inc. | 0001213900-21-063581 ↗ |
| 2021-12-15 | S-1/A | S-1/A (amendment) | Allarity Therapeutics, Inc. | 0001213900-21-065297 ↗ |
| 2021-12-16 | S-1/A | S-1/A (amendment) | Allarity Therapeutics, Inc. | 0001213900-21-065721 ↗ |
| 2021-12-20 | EFFECT | EFFECT (declared effective) | Allarity Therapeutics, Inc. | 9999999995-21-004760 ↗ |
| 2022-06-06 | EFFECT | EFFECT (declared effective) | Allarity Therapeutics, Inc. | 9999999995-22-001693 ↗ |
| 2023-03-14 | S-1 | S-1 (registration) | Allarity Therapeutics, Inc. | 0001213900-23-019717 ↗ |
| 2023-03-28 | S-1/A | S-1/A (amendment) | Allarity Therapeutics, Inc. | 0001213900-23-023688 ↗ |
| 2023-04-04 | S-1/A | S-1/A (amendment) | Allarity Therapeutics, Inc. | 0001213900-23-026733 ↗ |
| 2023-04-17 | S-1/A | S-1/A (amendment) | Allarity Therapeutics, Inc. | 0001213900-23-030032 ↗ |
| 2023-04-18 | EFFECT | EFFECT (declared effective) | Allarity Therapeutics, Inc. | 9999999995-23-000968 ↗ |
| 2023-04-20 | 424B4 | 424B4 (final prospectus) | Allarity Therapeutics, Inc. | 0001213900-23-031348 ↗ |
| 2023-06-07 | S-1 | S-1 (registration) | Allarity Therapeutics, Inc. | 0001213900-23-046958 ↗ |
| 2023-06-30 | S-1/A | S-1/A (amendment) | Allarity Therapeutics, Inc. | 0001213900-23-053628 ↗ |
| 2023-07-05 | EFFECT | EFFECT (declared effective) | Allarity Therapeutics, Inc. | 9999999995-23-001981 ↗ |
| 2023-07-07 | 424B4 | 424B4 (final prospectus) | Allarity Therapeutics, Inc. | 0001213900-23-055529 ↗ |
| 2023-10-19 | EFFECT | EFFECT (declared effective) | Allarity Therapeutics, Inc. | 9999999995-23-003019 ↗ |
| 2023-10-30 | S-1 | S-1 (registration) | Allarity Therapeutics, Inc. | 0001213900-23-081584 ↗ |
| 2023-11-29 | EFFECT | EFFECT (declared effective) | Allarity Therapeutics, Inc. | 9999999995-23-003487 ↗ |
| 2023-12-05 | S-1/A | S-1/A (amendment) | Allarity Therapeutics, Inc. | 0001213900-23-092856 ↗ |
| 2023-12-06 | S-1/A | S-1/A (amendment) | Allarity Therapeutics, Inc. | 0001213900-23-093287 ↗ |
| 2023-12-15 | S-1/A | S-1/A (amendment) | Allarity Therapeutics, Inc. | 0001213900-23-096150 ↗ |
| 2024-04-08 | S-1/A | S-1/A (amendment) | Allarity Therapeutics, Inc. | 0001213900-24-030912 ↗ |
| 2024-04-17 | S-1/A | S-1/A (amendment) | Allarity Therapeutics, Inc. | 0001213900-24-033604 ↗ |
| 2024-05-08 | RW | RW (withdrawal request) | Allarity Therapeutics, Inc. | 0001213900-24-040853 ↗ |
| 2025-06-24 | RW | RW (withdrawal request) | Allarity Therapeutics, Inc. | 0001213900-25-056913 ↗ |
| 2025-09-30 | EFFECT | EFFECT (declared effective) | Allarity Therapeutics, Inc. | 9999999995-25-003254 ↗ |
| 2025-12-05 | EFFECT | EFFECT (declared effective) | Allarity Therapeutics, Inc. | 9999999995-25-003560 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-17 | S-1/A | registration statement | - | - | Nasdaq ALLR | 1 | primary document; cover names 1 | document ↗ | ||
| 2023-04-20 | 424B4 | final prospectus | 2,869,330 | - | Nasdaq ALLR | 1 | primary document; shares headline, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Carchedi Steve | Director,Officer | Chief Executive Officer | 1 | 2021 | |
| Cullem James G. | Officer | SVP, Chief Business Officer | 1 | 2021 | |
| Foegh Marie | Officer | Chief Medical Officer | 1 | 2021 | |
| Jensen Soren Gade | Director | 1 | 2021 | ||
| Jensen Thomas | Officer | CEO; SVP, Information Technology | 3 | 2021–2026 | |
| Knudsen Jens Erik | Officer | Chief Financial Officer; Former Chief Financial Officer | 2 | 2021–2022 | |
| Knudsen Steen | Officer | Chief Scientific Officer | 1 | 2021 | |
| Maderis Gail J | Director | 1 | 2021 | ||
| Moore Duncan | Director | 1 | 2021 | ||
| Sass Benny | TenPercentOwner | 1 | 2021 | ||
| Sass & Larsen ApS | TenPercentOwner | 1 | 2021 | ||
| Sass Leon | TenPercentOwner | 1 | 2021 | ||
| Brown Joan Yvonne | Officer | Chief Financial Officer | 1 | 2022 | |
| Roth David | Director | 1 | 2022 | ||
| McLaughlin Gerald W. | Director | 4 | 2022–2026 | ||
| Vazzano Joseph Walter | Director | 3 | 2023–2025 | ||
| Benjamin Laura | Director | 3 | 2023–2025 | ||
| Epshinsky Alexander | Officer | CFO; Chief Financial Officer | 2 | 2024–2025 | |
| Graff Jeremy R. | Officer | CDO; See Remarks | 6 | 2024–2026 | |
| Ervin Jeffrey S | Officer | CFO; CHIEF FINANCIAL OFFICER | 2 | 2025–2026 | |
| Hoeiland Jesper | Director | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-02-02 | Allarity Therapeutics, Inc. | Biotechnology | $1,400,000 | $400,000 | 1 | 1 |
| 2023-09-21 | Allarity Therapeutics, Inc. | Biotechnology | Indefinite | $1,601,578 | 2 | 1 |
| 2023-04-28 | Allarity Therapeutics, Inc. | Biotechnology | $350,000 | $350,000 | 1 | 1 |
| 2023-04-28 | Allarity Therapeutics, Inc. | Biotechnology | Indefinite | $3,366,640 | 1 | 1 |
| 2023-03-01 | Allarity Therapeutics, Inc. | Biotechnology | $1,200,000 | $1,200,000 | 1 | 1 |
| 2021-05-27 | Allarity Therapeutics, Inc. | Biotechnology | $40,000,000 | $20,000,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Allarity Therapeutics, Inc. | MA | Form D private offerings | CIK (EXACT) |
| SEC filer | Allarity Therapeutics, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | ALLARITY THERAPEUTICS, INC. | MA | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, MA first:
- ERGO SCIENCE CORP MA
- MILLENNIUM PHARMACEUTICALS INC MA
- ESSENTIAL THERAPEUTICS INC MA
- ARQULE INC MA
- ASCENT PEDIATRICS INC MA
- EPIX Pharmaceuticals, Inc. MA
- PRAECIS PHARMACEUTICALS INC MA
- PARATEK PHARMACEUTICALS INC MA
- PREDIX PHARMACEUTICALS HOLDINGS INC MA
- CervoMed Inc. MA
In other datasets, the same topic (Health) in MA:
- Nonprofit: ABBIE M GRIFFIN HOSPITAL FUND (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health